you'll have more options to help patients get a suitable atypical antipsychotic

February 2011

The approval of Latuda (lurasidone) means you'll have more options to help patients get a suitable atypical antipsychotic....

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Psychiatry you'll have more options to help patients get a suitable atypical antipsychotic
Infectious Diseases New guidelines for treating methicillin-resistant S. aureus (MRSA) will change treatment of community-acquired skin infections
Neurology Pain Prescription combo analgesics will be limited to only 325 mg of acetaminophen per tab or cap
Neurology Pain Butrans (BYOO-trans), a new once-a-week C-III buprenorphine patch for chronic pain
Diabetes Cycloset, a new form of bromocriptine for type 2 diabetes
Cardiology questions about the safety of Multaq (dronedarone) for atrial fibrillation
Osteoporosis Atelvia (uh-TEL-vee-uh), a new delayed-release form of risedronate (Actonel), for postmenopausal osteoporosis
ADHD Kapvay (clonidine extended-release) for attention deficit hyperactivity disorder (ADHD) in children
Antidepressants confusion about generics for bupropion (Wellbutrin, Zyban, Budeprion, Buproban, etc)
Poison Prevention drugs that are toxic in young children
Vaccines CDC now recommends giving pertussis vaccine (Tdap) to SENIORS